Plant ID: NPO30669
Plant Latin Name: Gnaphalium affine
Taxonomy Genus: Gnaphalium
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
Antiperiodic; Antitussive; Expectorant; Febrifuge
China
HCAR2; | |
GAA; | |
MAPK1; | |
THRB; | |
ALDH1A1; | |
ABCG2; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
ATP-binding cassette | ABCG2 | ATP-binding cassette sub-family G member 2 | Q9UNQ0 | CHEMBL5393 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Nuclear hormone receptor subfamily 1 group A | THRB | Thyroid hormone receptor beta-1 | P10828 | CHEMBL1947 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Small molecule receptor (family A GPCR) | HCAR2 | Hydroxycarboxylic acid receptor 2 | Q8TDS4 | CHEMBL3785 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0032502; developmental process | GO:0009887; animal organ morphogenesis | 2.322E-04 | 8.114E-01 | GAA, MAPK1, THRB |
BP | GO:0007610; behavior | GO:0007610; behavior | 4.080E-04 | 8.114E-01 | GAA, MAPK1, THRB |
BP | GO:0008152; metabolic process | GO:0016052; carbohydrate catabolic process | 4.923E-04 | 8.114E-01 | ALDH1A1, GAA |
MF | GO:0003824; catalytic activity | GO:0004574; oligo-1,6-glucosidase activity | 6.212E-04 | 8.114E-01 | GAA |
MF | GO:0003824; catalytic activity | GO:0032450; maltose alpha-glucosidase activity | 9.316E-04 | 8.114E-01 | GAA |
MF | GO:0005488; binding | GO:0005497; androgen binding | 1.242E-03 | 8.667E-01 | ALDH1A1 |
MF | GO:0003824; catalytic activity | GO:0004558; alpha-1,4-glucosidase activity | 1.242E-03 | 8.667E-01 | GAA |
MF | GO:0003824; catalytic activity | GO:0001758; retinal dehydrogenase activity | 2.173E-03 | 8.943E-01 | ALDH1A1 |
MF | GO:0005215; transporter activity | GO:0008559; xenobiotic transmembrane transporting ATPase activity | 2.173E-03 | 8.943E-01 | ABCG2 |
CC | GO:0016020; membrane | GO:0005886; plasma membrane | 2.709E-02 | 1.000E+00 | ABCG2, GAA, HCAR2, MAPK1 |
CC | GO:0016020; membrane | GO:0044853; plasma membrane raft | 2.794E-02 | 1.000E+00 | MAPK1 |
CC | GO:0044464; cell part | GO:0035578; azurophil granule lumen | 2.794E-02 | 1.000E+00 | MAPK1 |
CC | GO:0044464; cell part | GO:0043204; perikaryon | 3.520E-02 | 1.000E+00 | MAPK1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 5.098E-04 | 4.792E-02 | THRB, MAPK1 |
09150 Organismal Systems | 09155 Excretory system | hsa04960 | Aldosterone-regulated sodium reabsorption | 1.164E-02 | 5.338E-02 | MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05219 | Bladder cancer | 1.224E-02 | 5.338E-02 | MAPK1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 8.967E-03 | 5.338E-02 | GAA |
09160 Human Diseases | 09161 Cancers | hsa05223 | Non-small cell lung cancer | 1.668E-02 | 5.338E-02 | MAPK1 |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04930 | Type II diabetes mellitus | 1.432E-02 | 5.338E-02 | MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05213 | Endometrial cancer | 1.550E-02 | 5.338E-02 | MAPK1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00500 | Starch and sucrose metabolism | 1.668E-02 | 5.338E-02 | GAA |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 1.698E-02 | 5.338E-02 | MAPK1 |
09150 Organismal Systems | 09156 Nervous system | hsa04730 | Long-term depression | 1.787E-02 | 5.338E-02 | MAPK1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
E00-E89: Endocrine, nutritional and metabolic diseases | Lipid metabolism disorder | E75-E78 | THRB; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Major depressive disorder | F32, F33, M32 | HCAR2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Hypothyroidism | E03 | THRB; |
I00-I99: Diseases of the circulatory system | Acute ischemic stroke | I61-I63 | HCAR2; |
I00-I99: Diseases of the circulatory system | Arteriosclerosis | I70 | HCAR2; |
I00-I99: Diseases of the circulatory system | Atherosclerosis | I70 | HCAR2; |
I00-I99: Diseases of the circulatory system | Cardiovascular disorder | I00-I99 | HCAR2; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Wound healing | T14.0-T14.1 | THRB; |
E00-E89: Endocrine, nutritional and metabolic diseases | High cholesterol levels in blood | E78.0 | THRB; |
E00-E89: Endocrine, nutritional and metabolic diseases | Hyperlipidaemia | E78 | THRB; HCAR2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Hyperthyroidism | E05 | THRB; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | HCAR2; |